Mission Statement
To advance the understanding of heterogeneous neurodegenerative disorders using novel molecular imaging tools and other biomarkers with the goal of developing personalized care and tailored treatments for people with cognitive decline.
The RABLab Mission Statement
The Lab
Dr. Rabinovici leads the PET program at the UCSF Memory & Aging Center, applying novel PET tracers along with structural and functional MRI to a broad spectrum of neurodegenerative diseases. Dr. Rabinovici is the Associate Director of the UCSF Alzheimer’s Disease Center, and Co-Lead of the ADRC Administrative and Imaging Cores. He serves as the national Study Chair of the original and the new Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) and as co-PI and PET Core Director of the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) investigating sporadic early-onset AD among other activities. Rabinovici Lab research focuses on utilizing multi-modal neuroimaging techniques and other biomarkers to improve early detection and diagnostic accuracy in dementia, and to study mechanisms of neurodegenerative diseases. The Rabinovici Lab has now closely collaborated for more than a decade with Dr. Bill Jagust group at UC Berkeley / Lawrence Berkeley National Laboratory to bring cutting-edge molecular imaging techniques to diverse patient cohorts, striving to improve patient care, study mechanisms of aging and neurodegenerative diseases, and accelerate drug development.